Directorio de personas
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grado: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicaciones

  • Bozic M; Álvarez Á; de Pablo C; Sanchez-Niño MD; Ortiz A; Dolcet X; Encinas M; Fernandez E; Valdivielso JM

    Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development

    PLOS ONE 10 -. .

    [doi:10.1371/journal.pone.0136863]

  • Gracia, M; Valdivielso, JM; Betriu, A; Abajo, M; Arroyo, D; Fernandez, ED

    SUBCLINICAL ATHEROMATOSIS PROGRESSION AND ASSOCIATED RISK FACTORS IN CHRONIC KIDNEY DISEASE. THE NEFRONA STUDY

    Atherosclerosis 241 14-15. .

    [doi:10.1016/j.atherosclerosis.2015.04.067]

  • Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Mojal S; Fernández E; Soler MJ

    Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    NEPHROLOGY DIALYSIS TRANSPLANTATION 30 1176-1185. .

    [doi:10.1093/ndt/gfv025]

  • Martin, M; Valls, J; Betriu, A; Fernandez, E; Valdivielso, JM

    Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference

    Atherosclerosis 241 264-270. .

    [doi:10.1016/j.atherosclerosis.2015.02.048]

  • Fernández-Laso V; Sastre C; Valdivielso JM; Fernández E; Martín-Ventura JL; Egido J; Blanco-Colio LM

    Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases

    Atherosclerosis 239 358-363. .

    [doi:10.1016/j.atherosclerosis.2015.01.040]

  • Bozic M; Valdivielso JM

    The potential of targeting NMDA receptors outside the CNS

    Expert Opinion On Therapeutic Targets 19 399-413. .

    [doi:10.1517/14728222.2014.983900]

  • Morgado-Pascual, Jose L.; Rayego-Mateos, Sandra; Valdivielso, Jose M.; Ortiz, Alberto; Egido, Jesus; Ruiz-Ortega, Marta

    Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells

    BioMed Research International -. .

    [doi:10.1155/2015/783538]

  • Martínez-Miguel P; Valdivielso JM; Medrano-Andrés D; Román-García P; Cano-Peñalver JL; Rodríguez-Puyol M; Rodríguez-Puyol D; López-Ongil S

    The active form of vitamin D, calcitriol, induces a complex dual upregulation of endothelin and nitric oxide in cultured endothelial cells

    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 307 1085-1096. .

    [doi:10.1152/ajpendo.00156.2014]

  • Arroyo, D.; Betriu, A.; Martinez-Alonso, M.; Vidal, T.; Valdivielso, J.M.; Fernández, E.

    Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study

    BMC NEPHROLOGY 15 168-168. .

    [doi:10.1186/1471-2369-15-168]

  • Bozic, M; Panizo, S; Sevilla, MA; Riera, M; Soler, MJ; Pascual, J; Lopez, I; Freixenet, M; Fernandez, E; Valdivielso, JM

    High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin

    JOURNAL OF HYPERTENSION 32 1822-1832. .

    [doi:10.1097/HJH.0000000000000261]

  • Valcheva P; Cardus A; Panizo S; Parisi E; Bozic M; Lopez Novoa JM; Dusso A; Fernández E; Valdivielso JM

    Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals

    Atherosclerosis 235 247-255. .

    [doi:10.1016/j.atherosclerosis.2014.05.911]

  • Betriu A; Martinez-Alonso M; Arcidiacono MV; Cannata-Andia J; Pascual J; Valdivielso JM; Fernández E

    Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study

    NEPHROLOGY DIALYSIS TRANSPLANTATION 29 1415-1422. .

    [doi:10.1093/ndt/gfu038]

Proyectos

  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Ajuts destinats a contractar personal investigador novell (FI)
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.